Rifaximin versus Nonabsorbable Disaccharides for the Treatment of Hepatic Encephalopathy: A Meta-Analysis

<table>Blood ammonia levels at the end of treatment: rifaximin versus nonabsorbable disaccharides. IV: inverse variance.</table>

Gastroenterology Research and Practice

Figure 4: Rifaximin versus Nonabsorbable Disaccharides for the Treatment of Hepatic Encephalopathy: A Meta-Analysis 